Investigative Site

Québec, Quebec G2J0C4

0 studies enrolling now · 4 studies all time

What they study most

Covid19, Irritable Bowel Syndrome With Diarrhea (IBS-D), Obesity, Overweight, Psoriasis

Studies at this site

• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed